Giuseppina Calvaruso

570 total citations
23 papers, 397 citations indexed

About

Giuseppina Calvaruso is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Giuseppina Calvaruso has authored 23 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 12 papers in Hematology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Giuseppina Calvaruso's work include Hemoglobinopathies and Related Disorders (12 papers), Iron Metabolism and Disorders (9 papers) and Lymphoma Diagnosis and Treatment (5 papers). Giuseppina Calvaruso is often cited by papers focused on Hemoglobinopathies and Related Disorders (12 papers), Iron Metabolism and Disorders (9 papers) and Lymphoma Diagnosis and Treatment (5 papers). Giuseppina Calvaruso collaborates with scholars based in Italy, United States and Belgium. Giuseppina Calvaruso's co-authors include Emilio Iannitto, Emanuele Ammatuna, Viviana Minardi, Aurelio Maggio, Vincenzo Abbadessa, Antonino Mulè, Antonio Craxı̀, R. Di Stefano, Ada Maria Florena and Donatella Ferraro and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer.

In The Last Decade

Giuseppina Calvaruso

20 papers receiving 369 citations

Peers

Countries citing papers authored by Giuseppina Calvaruso

Since Specialization

Citations

This map shows the geographic impact of Giuseppina Calvaruso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppina Calvaruso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppina Calvaruso more than expected).

Fields of papers citing papers by Giuseppina Calvaruso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppina Calvaruso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppina Calvaruso. The network helps show where Giuseppina Calvaruso may publish in the future.

Co-authorship network of co-authors of Giuseppina Calvaruso

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppina Calvaruso. A scholar is included among the top collaborators of Giuseppina Calvaruso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppina Calvaruso. Giuseppina Calvaruso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The First Case of Haemophagocytic Lymphohistiocytosis Triggered by the Booster Dose of Anti-SARS-CoV-2 Vaccine in a Patient with β-Thalassemia 2022 ·SHILAP Revista de lepidopterología ·Giuseppina Calvaruso, (unknown), Disma Renda, Simona Raso, Francesco Dieli, (unknown), Massimo Gentile, Antonio Carroccio, Aurelio Maggio	0
2	A Patient with Sickle Cell Disease and Recurrent Venous Thromboembolism after Renal Transplantation 2022 ·SHILAP Revista de lepidopterología ·Rosario Di Maggio, (unknown), Disma Renda, Giuseppina Calvaruso, Simona Raso, Lorella Pitrolo, Antonio Carroccio, Aurelio Maggio	0
3	Antimicrobial prophylaxis in patients with immune thrombocytopenia treated with rituximab: a retrospective multicenter analysis 2021 ·Annals of Hematology ·Simona Raso, Mariasanta Napolitano, Giulia Arrigo, (unknown), Alessandro Lucchesi, (unknown), Aurelio Maggio, Giuseppina Calvaruso, Ugo Consoli, Donato Mannina, Giulio Giordano, Marco Santoro, Vincenzo Accurso, Sergio Siragusa	3
4	Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia 2018 ·International Journal of Molecular Sciences ·Rosario Di Maggio, Matthew M. Hsieh, Xiongce Zhao, Giuseppina Calvaruso, Paolo Rigano, Disma Renda, John F. Tisdale, Aurelio Maggio	7
5	Phenotypic evaluations of HBB:c.93-23T>C, a nucleotide substitution in the IVS I nt 108 of β-globin gene 2017 ·Journal of Clinical Pathology ·(unknown), Filippo Cassarà, (unknown), Disma Renda, Giuseppina Calvaruso, (unknown), Cristina Passarello, Aurelio Maggio, Antonino Giambona	0
6	HBB: c.316-125A>G and HBB: c.316-42delC: Phenotypic Evaluations of Two Rare Changes in the Second Intron of the HBB Gene 2017 ·Hemoglobin ·(unknown), (unknown), Filippo Cassarà, Cristina Passarello, (unknown), Giuseppina Calvaruso, Disma Renda, Aurelio Maggio, Antonino Giambona	2
7	The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major‐intermedia dichotomy? 2016 ·British Journal of Haematology ·Angela Vitrano, Giuseppina Calvaruso, (unknown), (unknown), (unknown), Calogera Gerardi, Luciana Rigoli, Lorella Pitrolo, Liana Cuccia, Francesco Gagliardotto, Aldo Filosa, Vincenzo Caruso, (unknown), Saveria Campisi, Michele Rizzo, Luciano Prossomariti, Carmelo Fidone, (unknown), Rosario Di Maggio, Aurelio Maggio	38
8	Mesenchymal Fetal Stem Cells (FMSC) from Amniotic Fluid (AF): Expansion and Phenotypic Characterization 2015 ·Blood ·Maria Concetta Renda, Emanuela Fecarotta, (unknown), (unknown), Giuseppina Calvaruso, (unknown), (unknown), (unknown), Rosario Di Maggio, Angela Vitrano, Aurelio Maggio	4
9	Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5‐year long‐term Italian multicenter randomized clinical trial 2015 ·American Journal of Hematology ·Giuseppina Calvaruso, Angela Vitrano, Rosario Di Maggio, (unknown), (unknown), (unknown), Calogera Gerardi, Luciana Rigoli, (unknown), Lorella Pitrolo, Aurelio Maggio	35
10	Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi-Center Randomized Clinical Trial 2014 ·Blood ·Angela Vitrano, Giuseppina Calvaruso, Rosario Di Maggio, (unknown), (unknown), Marcello Capra, Aldo Filosa, Domenico Giuseppe D’Ascola, Carmelo Fidone, (unknown), Lorella Pitrolo, Calogera Gerardi, (unknown), (unknown), Maria Antonietta Romeo, Paolo Cianciulli, (unknown), Luciana Rigoli, Gian Luca Forni, Aurelio Maggio	2
11	Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major 2013 ·Blood Cells Molecules and Diseases ·Aldo Filosa, Angela Vitrano, Paolo Rigano, Giuseppina Calvaruso, Rita Barone, Marcello Capra, Liana Cuccia, Francesco Gagliardotto, Lorella Pitrolo, Luciano Prossomariti, Maddalena Casale, Vincenzo Caruso, Calogera Gerardi, Saveria Campisi, Paolo Cianciulli, Michele Rizzo, Giuseppe D'Ascola, Angela Ciancio, Aurelio Maggio	26
12	Cerebrovascular events in sickle cell‐beta thalassemia treated with hydroxyurea: A single center prospective survey in adult Italians 2013 ·American Journal of Hematology ·Paolo Rigano, (unknown), Giuseppina Calvaruso, Martin H. Steinberg, (unknown), Aurelio Maggio	19
13	Glutathione S Transferase Polymorphisms Influence on Iron Overload in β-Thalassemia Patients 2013 ·SHILAP Revista de lepidopterología ·(unknown), Giuseppina Calvaruso, (unknown), Aurelio Maggio, (unknown), (unknown)	5
14	Long‐term use of deferiprone significantly enhances left‐ventricular ejection function in thalassemia major patients 2012 ·American Journal of Hematology ·Aurelio Maggio, Angela Vitrano, (unknown), Marcello Capra, Liana Cuccia, Francesco Gagliardotto, Lorella Pitrolo, Luciano Prossomariti, Aldo Filosa, Vincenzo Caruso, Calogera Gerardi, Saveria Campisi, Paolo Cianciulli, Michele Rizzo, Giuseppe D'Ascola, Angela Ciancio, Rosario Di Maggio, Giuseppina Calvaruso, (unknown), Paolo Rigano	30
15	Response-Guided ABVD Chemotherapy plus Involved-Field Radiation Therapy for Intermediate-Stage Hodgkin Lymphoma in the Pre–Positron Emission Tomography Era: A Gruppo Italiano Studio Linfomi (GISL) Prospective Trial 2009 ·Clinical Lymphoma & Myeloma ·Emilio Iannitto, Viviana Minardi, Paolo G. Gobbi, Giuseppina Calvaruso, Claudio Tripodo, Luigi Marcheselli, Stefano Luminari, Francesco Merli, Luca Baldini, Caterina Stelitano, Vincenzo Callea, Mario Petrini, F. Angrilli, Giovanni Quarta, Daniele Vallisa, Stefano Molica, (unknown), Giuseppe Polimeno, Maura Brugiatelli, Massimo Federico	9
16	Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphoma 2005 ·European Journal Of Haematology ·Emilio Iannitto, Viviana Minardi, Vincenzo Callea, Caterina Stelitano, Giuseppina Calvaruso, Claudio Tripodo, Gerlando Quintini, Stefano De Cantis, Achille Ambrosetti, Giovanni Pizzolo, Vito Franco, Ada Maria Florena, Vincenzo Abbadessa	9
17	Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytes 2005 ·European Journal Of Haematology ·Emilio Iannitto, Viviana Minardi, Giuseppina Calvaruso, Emanuele Ammatuna, Ada Maria Florena, Antonino Mulè, Claudio Tripodo, Gerlando Quintini, Vincenzo Abbadessa	23
18	Hepatitis B virus reactivation and alemtuzumab therapy 2005 ·European Journal Of Haematology ·Emilio Iannitto, Viviana Minardi, Giuseppina Calvaruso, Antonino Mulè, Emanuele Ammatuna, (unknown), Donatella Ferraro, Vincenzo Abbadessa, Antonio Craxı̀, R. Di Stefano	95
19	Splenic marginal zone lymphoma with or without villous lymphocytes 2004 ·Cancer ·Emilio Iannitto, Achille Ambrosetti, Emanuele Ammatuna, (unknown), Ada Maria Florena, Claudio Tripodo, Viviana Minardi, Giuseppina Calvaruso, Maria Enza Mitra, Giovanni Pizzolo, Fabio Menestrina, Vito Franco	55
20	Long-lasting remission of primary hepatic lymphoma and hepatitis C virus infection achieved by the alpha-interferon treatment 2004 ·The Hematology Journal ·Emilio Iannitto, Emanuele Ammatuna, Claudio Tripodo, C Marino, Giuseppina Calvaruso, Ada Maria Florena, Giuseppe Montalto, Vito Franco	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact